华领医药-B

02552
2.0150.98% ( -0.020 )
延迟 已收盘: 11月20日 16:08:00

股东

全部股东

股东类型

  • 公众及其他65.27%
  • 风投/私募28.08%
  • 个人与内部人士5.57%
  • 机构投资者1.09%

主要股东

主要股东 最新
股东
Arch Venture Partners, L.P.
12.53%1.25 亿0.00%+0
VR Management, LLC
10.36%1.03 亿0.00%+0
WuXi PharmaTech Healthcare Fund I General Partner L.P.
5.19%5,180.76 万0.00%+0
Li ChenFounder, CEO, Member of Portfolio Advisory Board & Executive Director
4.06%4,053.87 万0.08%+75.00 万
Chien Cheng LinExecutive VP, Chief Strategy Officer & Executive Director
0.85%849.93 万0.00%+0
Yi ZhangSenior VP of Pharma Development, Chief Medical Officer – China and Executive Director
0.64%637.50 万0.00%+0
JP Morgan Asset Management
0.53%524.40 万0.00%+0
State Street Investment Management
0.21%207.30 万<0.01%-2.40 万
Dimensional Fund Advisors LP
0.17%165.30 万0.01%+11.75 万
American Century Investment Management Inc
0.16%161.55 万0.09%+91.75 万
China Universal Asset Management Company Ltd.
0.03%31.35 万0.00%+0
Robert Taylor NelsenNon-Executive Chairman
0.02%15.00 万0.00%+0
Yiu Wa TsuiIndependent Non-Executive Director
<0.01%2.40 万0.00%+0
CIBC Asset Management Inc.
<0.01%6,000.000.00%+0
E Fund Management Co., Ltd.
<0.01%217.000.00%+0